Sign in
4

Changes in Ownership

IGC Pharma, Inc. Filed Acc 0001185185-17-002591

Exec. Chairman & CEO sold 154,950 shares at an average $0.86 ($132,909)

From the SEC's structured data for this filing

Trades in this filing

MUKUNDA RAM · Exec. Chairman & CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2017-12-07 Sale : show line 1 in the form −70,000 $0.85 $59,500 2,526,944 D
2017-12-07 Sale : show line 2 in the form −30,000 $0.86 $25,800 2,496,944 D
2017-12-08 Sale : show line 3 in the form −9,950 $0.83 $8,259 2,486,994 D
2017-12-08 Sale : show line 4 in the form −10,000 $0.84 $8,400 2,476,994 D
2017-12-08 Sale : show line 5 in the form −10,000 $0.85 $8,500 2,466,994 D
2017-12-08 Sale : show line 6 in the form −5,000 $0.88 $4,400 2,461,994 D
2017-12-08 Sale : show line 7 in the form −15,000 $0.90 $13,500 2,446,994 D
2017-12-08 Sale : show line 8 in the form −5,000 $0.91 $4,550 2,441,994 D
Open-market sales · 154,950 sh · avg $0.86 · $132,909
Loading xslF345X03/form4-mukunda120817.xml…